tirzepatide vs semaglutide mechanism When it comes to the different types of GLP-1s, like vs. semaglutide, what's the difference? Our endocrine clinical pharmacist explains Semaglutide vs. Tirzepatide for Obesity

Emily Cooper, Andrea Taylor, and Mark Wright take on one of the biggest misinformation waves in popular health media: the rise of microdosed GLP1s and socalled GLP1 diets. As GLP1 medications dominate headlines and social media feeds, the hosts cut through the noise to explain whats actually safe, whats marketing hype, and why restrictive diets go against metabolic science

Published Research Highlights Coskun and colleagues described the discovery and in-vitro/in-vivo characterization of LY3437943 as a single peptide with potent activity at GLP-1R, GIPR, and GCGR, establishing the molecules foundational pharmacology (Coskun et al., 2022, Cell Metabolism)

Alicic RZ, et al

47 Model building The initial template of the TMDs in GLP-2R was generated using SWISS-MODEL